Somatostatin treatment can induce extensive fibrosis in growth hormone-producing adenoma

Acta Neurochir (Wien). 2016 Mar;158(3):441-3. doi: 10.1007/s00701-016-2714-7. Epub 2016 Jan 23.

Authors

Johannes Kerschbaumer¹, Daniel Pinggera², Patrizia Moser³, Andrea Hofmann⁴, Claudius Thomé², Christian Franz Freyschlag²

Affiliations

¹ Department of Neurosurgery, Innsbruck Medical University, Anichstrasse 35, 6020, Innsbruck, Austria. [email protected].
² Department of Neurosurgery, Innsbruck Medical University, Anichstrasse 35, 6020, Innsbruck, Austria.
³ Department of Pathology, Innsbruck Medical University, Innsbruck, Austria.
⁴ Department of Nuclear medicine and Endocrinology, Paracelsus Medical University, Salzburg, Austria.

PMID: 26801514
DOI: 10.1007/s00701-016-2714-7

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adenoma / blood
Adenoma / drug therapy*
Adenoma / pathology
Adult
Fibrosis / etiology
Growth Hormone / blood*
Humans
Male
Somatostatin / adverse effects*
Somatostatin / therapeutic use

Substances

Somatostatin
Growth Hormone